CAPTRUST Financial Advisors’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $277K | Buy |
2,146
+451
| +27% | +$64.8K | ﹤0.01% | 2443 |
|
|
2025
Q4 | $242K | Sell |
1,695
-2,654
| -61% | -$356K | ﹤0.01% | 2401 |
|
|
2025
Q3 | $522K | Sell |
4,349
-495
| -10% | -$62.7K | ﹤0.01% | 1788 |
|
|
2025
Q2 | $640K | Buy |
4,844
+2,573
| +113% | +$349K | ﹤0.01% | 1588 |
|
|
2025
Q1 | $315K | Sell |
2,271
-528
| -19% | -$81.9K | ﹤0.01% | 1908 |
|
|
2024
Q4 | $434K | Sell |
2,799
-170
| -6% | -$28.8K | ﹤0.01% | 1681 |
|
|
2024
Q3 | $541K | Buy |
2,969
+1,043
| +54% | +$154K | ﹤0.01% | 1528 |
|
|
2024
Q2 | $229K | Buy |
1,926
+41
| +2% | +$4.31K | ﹤0.01% | 1968 |
|
|
2024
Q1 | $202K | Sell |
1,885
-285
| -13% | -$28.3K | ﹤0.01% | 1989 |
|
|
2023
Q4 | $216K | Sell |
2,170
-5,196
| -71% | -$508K | ﹤0.01% | 2342 |
|
|
2023
Q3 | $877K | Buy |
7,366
+1,986
| +37% | +$296K | ﹤0.01% | 1284 |
|
|
2023
Q2 | $959K | Buy |
+5,380
| New | +$987K | ﹤0.01% | 1231 |
|
|
2022
Q3 | – | Sell |
-1,323
| Closed | -$217K | – | 2990 |
|
|
2022
Q2 | $217K | Buy |
1,323
+53
| +4% | +$10.2K | ﹤0.01% | 1647 |
|
|
2022
Q1 | $283K | Buy |
1,270
+635
| +100% | +$142K | ﹤0.01% | 1476 |
|
|
2021
Q4 | $151K | Sell |
635
-24
| -4% | -$5.61K | ﹤0.01% | 1846 |
|
|
2021
Q3 | $154K | Sell |
659
-1,421
| -68% | -$298K | ﹤0.01% | 1740 |
|
|
2021
Q2 | $428K | Sell |
2,080
-850
| -29% | -$175K | ﹤0.01% | 1054 |
|
|
2021
Q1 | $602K | Buy |
2,930
+479
| +20% | +$101K | 0.01% | 885 |
|
|
2020
Q4 | $526K | Buy |
2,451
+346
| +16% | +$67.1K | 0.01% | 809 |
|
|
2020
Q3 | $379K | Sell |
2,105
-37
| -2% | -$6.97K | 0.01% | 799 |
|
|
2020
Q2 | $391K | Sell |
2,142
-50
| -2% | -$9.93K | 0.01% | 791 |
|
|
2020
Q1 | $444K | Sell |
2,192
-940
| -30% | -$181K | 0.01% | 617 |
|
|
2019
Q4 | $581K | Buy |
3,132
+2,466
| +370% | +$424K | 0.01% | 642 |
|
|
2019
Q3 | $106K | Buy |
666
+163
| +32% | +$32.5K | ﹤0.01% | 762 |
|
|
2019
Q2 | $127K | Sell |
503
-8
| -2% | -$1.85K | ﹤0.01% | 675 |
|
|
2019
Q1 | $122K | Buy |
511
+84
| +20% | +$20.1K | 0.01% | 635 |
|
|
2018
Q4 | $98K | Buy |
427
+251
| +143% | +$61.9K | 0.01% | 592 |
|
|
2018
Q3 | $50K | Sell |
176
-11
| -6% | -$3.22K | ﹤0.01% | 773 |
|
|
2018
Q2 | $55K | Sell |
187
-120
| -39% | -$32.8K | ﹤0.01% | 658 |
|
|
2018
Q1 | $75K | Buy |
307
+10
| +3% | +$2.35K | ﹤0.01% | 508 |
|
|
2017
Q4 | $64K | Buy |
+297
| New | +$60.1K | ﹤0.01% | 540 |
|
Other funds holding ICUI
VPM
VCM
RRAM
CAPTRUST Financial Advisors's ICUI Position: Q1 2026 in Review
CAPTRUST Financial Advisors increased its ICU Medical (ICUI) stake by 27% in Q1 2026, buying an estimated $64.8K and bringing the position to 2,146 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2443.
CAPTRUST Financial Advisors first reported a position in ICUI in Q4 2017 and has held it in 31 quarters since. The position peaked at $959K in Q2 2023. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- CAPTRUST Financial Advisors held 2,146 shares of ICU Medical worth $277K as of Q1 2026.
- CAPTRUST Financial Advisors bought 451 ICU Medical shares in Q1 2026, an estimated $64.8K.
- ICU Medical made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2443 holding.
- CAPTRUST Financial Advisors first reported a position in ICU Medical in Q4 2017 and has held it in 31 quarters since.
- CAPTRUST Financial Advisors's ICU Medical position peaked at $959K in Q2 2023.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.